Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marja-Riitta Taskinen

Showing results (21-30 of 230) with videos related to

Pageof 23
Sort By:
Current Atherosclerosis Reports|May 22, 2019
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVDMarja-Riitta Taskinen, Chris J Packard, Jan Borén
Frontiers in Physiology|December 5, 2015
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in HumansMartin Adiels, Adil Mardinoglu, Marja-Riitta Taskinen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2014
Postprandial hypertriglyceridemia as a coronary risk factorJan Borén, Niina Matikainen, Martin Adiels, et al.
Lipids in Health and Disease|September 25, 2010
Effect of HDL composition and particle size on the resistance of HDL to the oxidationNakanishi Shuhei, Sanni Söderlund, Matti Jauhiainen, et al.
Current Opinion in Lipidology|November 30, 2016
Kinetics of plasma triglycerides in abdominal obesityElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Journal of Lipid Research|June 5, 2003
Determinants of low HDL levels in familial combined hyperlipidemiaAino Soro, Matti Jauhiainen, Christian Ehnholm, et al.
Nature Reviews. Endocrinology|June 23, 2010
PPARalpha: an emerging therapeutic target in diabetic microvascular damageAnne Hiukka, Marianna Maranghi, Niina Matikainen, et al.
Nature Reviews. Cardiology|March 23, 2022
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemiaJan Borén, Marja-Riitta Taskinen, Elias Björnson, et al.
Annals of Medicine|May 25, 2006
Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDLAino Soro-Paavonen, Jukka Westerbacka, Christian Ehnholm, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndromeMartin Adiels, Sven-Olof Olofsson, Marja-Riitta Taskinen, et al.
Pageof 23

Showing results (21-30 of 230) with videos related to

Sort By:
Pageof 23
Current Atherosclerosis Reports|May 22, 2019
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVDMarja-Riitta Taskinen, Chris J Packard, Jan Borén
Frontiers in Physiology|December 5, 2015
Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in HumansMartin Adiels, Adil Mardinoglu, Marja-Riitta Taskinen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 11, 2014
Postprandial hypertriglyceridemia as a coronary risk factorJan Borén, Niina Matikainen, Martin Adiels, et al.
Lipids in Health and Disease|September 25, 2010
Effect of HDL composition and particle size on the resistance of HDL to the oxidationNakanishi Shuhei, Sanni Söderlund, Matti Jauhiainen, et al.
Current Opinion in Lipidology|November 30, 2016
Kinetics of plasma triglycerides in abdominal obesityElias Björnson, Martin Adiels, Marja-Riitta Taskinen, et al.
Journal of Lipid Research|June 5, 2003
Determinants of low HDL levels in familial combined hyperlipidemiaAino Soro, Matti Jauhiainen, Christian Ehnholm, et al.
Nature Reviews. Endocrinology|June 23, 2010
PPARalpha: an emerging therapeutic target in diabetic microvascular damageAnne Hiukka, Marianna Maranghi, Niina Matikainen, et al.
Nature Reviews. Cardiology|March 23, 2022
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemiaJan Borén, Marja-Riitta Taskinen, Elias Björnson, et al.
Annals of Medicine|May 25, 2006
Metabolic syndrome aggravates the increased endothelial activation and low-grade inflammation in subjects with familial low HDLAino Soro-Paavonen, Jukka Westerbacka, Christian Ehnholm, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 21, 2008
Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndromeMartin Adiels, Sven-Olof Olofsson, Marja-Riitta Taskinen, et al.
Pageof 23